Daily measurements of blood CD34+ cells after stem cell mobilization predict stem cell yield and posttransplant hematopoietic recovery

被引:40
作者
Remes, K
Matinlauri, I
Grenman, S
Itala, M
Kauppila, M
Pelliniemi, TT
Salminen, E
Vanharanta, R
Rajamaki, A
机构
[1] UNIV TURKU,CENT HOSP,DEPT CENT LAB,FIN-20520 TURKU,FINLAND
[2] UNIV TURKU,CENT HOSP,DEPT OBSTET & GYNECOL,FIN-20520 TURKU,FINLAND
[3] UNIV TURKU,CENT HOSP,DEPT ONCOL,FIN-20520 TURKU,FINLAND
来源
JOURNAL OF HEMATOTHERAPY | 1997年 / 6卷 / 01期
关键词
D O I
10.1089/scd.1.1997.6.13
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The value of daily monitoring of the blood CD34+ cell concentration as a guide to the optimal timing of stem cell harvests was studied in 60 patients who underwent 66 stem cell mobilizations and 189 leukaphereses. There was a highly significant correlation between the blood CD34+ count and the CD34+ cell content in the apheresis product of the same day (r = 0.904, p < 0.01). Thus, the target yield of 4 x 10(6) CD34+ cells/kg can be harvested in one or two leukaphereses when the blood CD34+ cell count exceeds 50 x 10(6)/L. However, an insufficient harvest is to be expected when the blood CD34+ cell count is below 20 x 10(6)/L. The data from 35 autologous blood cell transplantations with a minimum CD34+ cell yield of 1.5 x 10(6)/kg showed that the recovery of blood neutrophil counts to 1.0 x 10(9)/L occurred in all patients within 9-14 days, but the time to recovery of the platelet counts to 20 x 10(9)/L may exceed 14 days, especially if the CD34+ cell content is below 4 x 10(6)/kg. Daily monitoring of blood CD34+ cell counts is a rapid and reliable means to guide the timing of stem cell collections. The count predicts well the CD34+ cell content of the harvests, the number of leukaphereses needed, and the speed of hematopoietic recovery.
引用
收藏
页码:13 / 19
页数:7
相关论文
共 33 条
[1]  
BENSINGER W, 1993, BLOOD, V81, P3158
[2]   PERIPHERAL-BLOOD STEM-CELLS (PBSCS) COLLECTED AFTER RECOMBINANT GRANULOCYTE-COLONY-STIMULATING FACTOR (RHG-CSF) - AN ANALYSIS OF FACTORS CORRELATING WITH THE TEMPO OF ENGRAFTMENT AFTER TRANSPLANTATION [J].
BENSINGER, WI ;
LONGIN, K ;
APPELBAUM, F ;
ROWLEY, S ;
WEAVER, C ;
LILLEBY, K ;
GOOLEY, T ;
LYNCH, M ;
HIGANO, T ;
KLARNET, J ;
CHAUNCEY, T ;
STORB, R ;
BUCKNER, CD .
BRITISH JOURNAL OF HAEMATOLOGY, 1994, 87 (04) :825-831
[3]  
BRICE P, 1992, BONE MARROW TRANSPL, V9, P337
[4]  
BRUGGER W, 1992, BLOOD, V79, P1193
[5]  
ELIAS AD, 1992, BLOOD, V79, P3036
[6]   USE OF FLOW CYTOMETRIC CD34 ANALYSIS TO QUANTIFY HEMATOPOIETIC PROGENITOR CELLS [J].
FRITSCH, G ;
BUCHINGER, P ;
PRINTZ, D .
LEUKEMIA & LYMPHOMA, 1993, 10 (06) :443-451
[7]  
GORDON MY, 1995, BONE MARROW TRANSPL, V15, P659
[8]   PARTIAL REPLACEMENT OF SERUM BY SELENITE, TRANSFERRIN, ALBUMIN AND LECITHIN IN HEMATOPOIETIC CELL-CULTURES [J].
GUILBERT, LJ ;
ISCOVE, NN .
NATURE, 1976, 263 (5578) :594-595
[9]  
Haas R, 1994, J Hematother, V3, P323, DOI 10.1089/scd.1.1994.3.323
[10]  
HENON PR, 1992, BONE MARROW TRANSPL, V9, P285